Clinical value of contrast-enhanced ultrasound in early diagnosis of hepatocellular carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 10

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Oct 15, 2025; 17(10): 109506
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.109506

Table 2 Pathological typing

Project	n (%)
Conventional type HCC	89 (71.20)
Clear cell HCC	24 (19.20)
Fibrolamellar HCC	12 (9.60)
Grade I (highly differentiated)	18 (14.40)
Grade II (moderate differentiation)	64 (51.20)
Grade III-IV (low differentiation)	43 (34.40)
Ki-67 > 20%	47 (37.60)
CK19 positive	29 (23.20)
AFP positive	98 (78.40)
Glypican-3 positive	113 (90.40)
MVI positive	42 (33.60)
Capsule invasion	31 (24.80)

HCC: Hepatocellular carcinoma; Ki-67: Antigen Kiel 67; CK19: Cytokeratin 19; AFP: Alpha-fetoprotein; MVI: Microvascular invasion.

Citation: Dong Y, Chen LP, He JG, Yang QQ, Hu ZW. Clinical value of contrast-enhanced ultrasound in early diagnosis of hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(10): 109506
URL: https://www.wjgnet.com/1948-5204/full/v17/i10/109506.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i10.109506

Dong Y, Chen LP, He JG, Yang QQ, Hu ZW. Clinical value of contrast-enhanced ultrasound in early diagnosis of hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(10): 109506 [PMID: 41114101 DOI: 10.4251/wjgo.v17.i10.109506]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.